Comments on: ‘Critical assessment of a prolonged-release EE/DNG contraceptive safety analysis’ - a letter to the editor to the European Jornal of Contraception by Jonathan Douxfils et al

The European Journal of Contraception & Reproductive Health Care 2026 Open access

Read full text
Authors: Giovanni Grandi, Inka Wiegratz, Alejandro Muñoz, Enrico Colli, Alicyoy Angulo, Pedro‐Antonio Regidor
DOI: 10.1080/13625187.2026.2626431
Cited by: 0
References: 2

Abstract

We read with great interest the Comment by Douxfils et al. which evaluates a modern combined oral contraceptive containing 2 mg dienogest (DNG) and 0.02 mg ethinyl oestradiol (EE).While the authors...

Fields of Study & Subjects

Reproductive Health and Contraception Pharmacovigilance and Adverse Drug Reactions Pregnancy and Medication Impact

Publication details

Journal / source
The European Journal of Contraception & Reproductive Health Care
Volume
31
Issue
3
Pages
201–203
Publication date
17 February 2026
Language
EN